Skip to main content
OpenTrials

Clinical trial condition

Flaviviridae Infections

Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.

2,144 public trials 77 recruiting studies
Refine in advanced search Browse all conditions

Flaviviridae Infections trial results

Completed

A Dose Ranging Study Of PF-00868554 In Combination With PEGASYS And COPEGUS In Patients With Chronic Hepatitis C Genotype 1 Infection

NCT00720434

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Pfizer Investigational Site La Jolla, California, United States
  • Pfizer Investigational Site San Francisco, California, United States
  • Pfizer Investigational Site Orlando, Florida, United States
  • Pfizer Investigational Site Springfield, Massachusetts, United States
View Trial Details
Completed

A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis C

NCT01591668

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Woodland International Research Group Little Rock, Arkansas, United States
  • Avail Clinical Research, LLC DeLand, Florida, United States
  • Orlando Clinical Research Center Orlando, Florida, United States
  • Kansas City Gastroenterology and Hepatology Kansas City, Missouri, United States
View Trial Details
Completed

Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3

NCT00411385

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Scripps Clinic La Jolla, California, United States
  • California Pacific Medical Center San Francisco, California, United States
  • University of Colorado Denver, Colorado, United States
View all 159 locations
View Trial Details
Completed

Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients

NCT00402428

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UCSF Fresno Fresno, California, United States
  • Scripps Clinic La Jolla, California, United States
View all 165 locations
View Trial Details

Related conditions